Neurology MRI

Catch up on a variety of new FDA clearances in radiology from the past week.

For patients with cardiac dysfunction related to neoadjuvant chemotherapy for invasive breast cancer, new MRI research shows increased risks for concurrent decreases in total brain volume and white matter volume.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

In an interview, W. Taylor Kimberly, M.D., discussed recent research showing that multidirectional diffusion-weighted imaging (DWI) on low-field MRI yielded a 95 percent positive predictive value (PPV) for detecting acute ischemic stroke.

Use of an MRI-based deep learning model also led to a greater than 33 percent increase in detecting brain metastases less than or equal to 3 mm, according to newly published research.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

The MEDRAD MRXperion MR Injection System is cleared for use with low-field and high-field MRI platforms, including 7T MRI.

Catch up on the top radiology content of the past week.

Catch up on the most-well viewed radiology content in February 2026.

Catch up on the most well-viewed video interviews from Diagnostic Imaging in February 2026.

Catch up on the top AI-related news and research in radiology over the past month.

In a recent interview, Jeremy Heit, M.D., Ph.D., discussed key neuroimaging takeaways from changes to the updated guideline from the American Heart Association and the American Stroke Association for early evaluation and management of patients with acute ischemic stroke.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Catch up on the top radiology content of the past week.

Previously approved by the FDA in 2022, the macrocyclic gadolinium-based MRI contrast agent gadopiclenol can now be utilized to detect lesions with abnormal vascularity in the central nervous system and other parts of the body for children under the age of two.

The FDA clearances include the 1.5T SIGNA Sprint with Freelium MRI platform, the 3T SIGNA Bolt MRI system and the AI-powered SIGNA One, which reportedly enhances MRI workflow efficiencies.

In a recent interview, Yulin Ge, M.D., discussed emerging research showing correlations between brain MRI findings in patients with Long Covid and established blood biomarkers for Alzheimer’s disease.

Sharing his perspective as well as insights from recently published research, Benjamin Kann, M.D., discussed the utility of AI foundation models for accessing an array of diagnostic and prognostic data from brain MRI scans.

Catch up on the top radiology content of the past week.

In a recent interview, Benjamin Kann, M.D., discussed new research highlighting the capability of an AI foundation model to obtain a variety of diagnostic and prognostic data from brain MRI scans.

Catch up on the top radiology content of the past week.

Catch up on a variety of new FDA clearances in radiology from the past week.

In a recent interview from the International Stroke Conference, Jeremy Heit, M.D., Ph.D., discussed new research suggesting that AI may offer better assessment than neuroradiologists of aneurysm growth on computed tomography or magnetic resonance angiography scans.

The Ascent3T Neonatal Magnetic Resonance Imaging System is reportedly the first high-field 3T system geared to neonatal applications.